On 6 July 2022, the company issued £1 million of £1 fixed rate secured Convertible Loan Notes, the terms of which were amended on 27 January 2023 and 15 August 2024. The conversion price per ordinary share was based a valuation of all shares at the time of exercise of £1.5 million. The redemption date was agreed as 5 days business days after the company receives a redemption notice or 31 December 2024. On redemption, the principal amount is repayable together with accrued interest.
On initial recognition, the Convertible Loan Notes were separated into liability and equity components in the accounts. The liability component was initially measured at the fair value of a comparable liability without a conversion feature. The equity component, representing the conversion option, was measured as the residual difference between the fair value of the instrument as a whole and the fair value of the liability component. Directly attributable issue costs were allocated between the two components in proportion to their initial values. The equity component will not be subsequently remeasured.
The liability component is measured at amortised cost using the effective interest method. Finance costs calculated using an effective interest rate of 12% increase the carrying amount of the liability, while interest payments reduce it.
The Convertible Loan Notes are secured by fixed and floating charges over the company’s assets. The company has also given a negative pledge restricting the creation of further security over its assets, subject to the terms of the agreement.
As the redemption date of 31 December 2024 has lapsed and no redemption notice has been received by the company, the entire liability component of the Convertible Loan Notes, including accrued interest payable, has been presented as liabilities falling due within one year. Comparative amounts have been restated as further described in the notes.